For example, in a study conducted by Zhang et al. in patients with small-cell lung cancer (n = 216), the integration of the IL-6 and CRP levels with the MASCC score was found to independently predict the development of febrile neutropenia and significantly improved risk estimation [23]. The gene discussed is IL6; the disease is small cell lung carcinoma.